Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of NWBO will - over the next 2 Weeks and hit - by . In that time frame, NWBO's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
NWBO shares rose +0.77% in Thursday, September 10, 2026's trading session, rising from a previous close of $0.17 to move at $0.17. The stock demonstrated notable intraday movement (see NWBO's key stats for a full breakdown), fluctuating between $0.17 and $0.17, a +3.03% trading range. While recent weeks have seen some volatility, NWBO has managed to secure a -5.10% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 880.6K shares changing hands, 1.77M fewer than the previous session. This amounted to $149.70K in total market activity.
Will NWBO Continue Its Trend?
According to analyst ratings and projections for NWBO, Northwest Biotherapeutics, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators currently suggest a bearish sentiment for NWBO. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the NWBO stock forecast, now is not the best time to buy NWBO stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on NWBO covering social and institutional perspectives.
NWBO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into NWBO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.31% to 45.96%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.90%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.58%, maintains a neutral outlook for the long term. Insights into NWBO's shareholder base show how institutional investors are positioning themselves during these momentum shifts

